TY - JOUR
AU - Kerr, Steven
AU - Joy, Mark
AU - Torabi, Fatemeh
AU - Bedston, Stuart
AU - Akbari, Ashley
AU - Agrawal, Utkarsh
AU - Beggs, Jillian
AU - Bradley, Declan T.
AU - Chuter, Antony
AU - Docherty, Annemarie B.
AU - Ford, David V.
AU - Hobbs, Richard
AU - Katikireddi, Srinivasa Vittal
AU - Lowthian, Emily
AU - de Lusignan, Simon
AU - Lyons, Ronan A.
AU - Marple, James
AU - McCowan, Colin
AU - McGagh, Dylan
AU - Jim McMenamin
AU - Moore, Emily
AU - Murray, Josephine-Louise K.
AU - Owen, Rhiannon K.
AU - Pan, Jiafeng
AU - Ritchie, Lewis
AU - Shah, Syed Ahmar
AU - Shi, Ting
AU - Stock, Sarah J.
AU - Tsang, Ruby S. M.
AU - Vasileiou, Eleftheria
AU - Woolhouse, Mark
AU - Simpson, Colin R.
AU - Robertson, Chris
AU - Sheikh, Aziz
PY - 2022
DA - February
TI - First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: a pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales
JO - PLoS Medicine
VL - 19
IS - 2
DO - https://doi.org/10.1371/journal.pmed.1003927
AB - BackgroundSeveral countries restricted the administration of ChAdOx1 to older age groups in 2021 over safety concerns following case reports and observed versus expected analyses suggesting a possible association with cerebral venous sinus thrombosis (CVST). Large datasets are required to precisely estimate the association between Coronavirus Disease 2019 (COVID-19) vaccination and CVST due to the extreme rarity of this event. We aimed to accomplish this by combining national data from England, Scotland, and Wales.
UR - http://hdl.handle.net/10023/24953
KW - Coronavirus (COVID-19)
ER